MedVasc and the Solutio™ catheter system were recently featured in Venous News, highlighting the company’s ongoing development efforts and the clinical need Solutio is designed to address.
Solutio is a novel catheter technology being developed to support the delivery of tumescent anesthesia from inside the vein during endothermal treatment of varicose veins. The technology aims to simplify an important step in the procedure while improving the treatment experience for both patients and physicians.
The article also highlights MedVasc’s recent financing round, which supports the continued development of the technology and the company’s future regulatory and commercialization activities.
“We are pleased to see growing interest in technologies that address unmet needs in venous disease treatment,” said Cathrin Johansson, CEO of MedVasc. “The recognition from Venous News helps raise awareness of both the clinical challenge and the potential of our solution.”
Read article here: https://venousnews.com/us-fda-clearance-next-step-for-pain-lessening-varicose-vein-surgery-technology/
Solutio is currently under development and has not been cleared or approved by the U.S. Food and Drug Administration (FDA).
